Novo Nordisk A/S (NVO)
NVONYSEBiotechnology: Pharmaceutical Preparations
$40.52
-0.8600 (-2.08%) today
Regular session, Nov 10, 12:11 PM ET
- Market cap
- $179.42bn
- P/E
- 10.4
- EPS, last 4 quarters
- $3.89
- Dividend yield
- –
- Day range
- $40.38 to $40.80
- 52-week range
- $35.12 to $64.16
- Average volume
- 1.07m
- Previous close
- $41.38
Analysts
5 coveringUnderperform0 buy, 4 hold, 1 sell
Targets a year out average $43.04, +6.2% from here
Earnings
next estimate $0.6800Next report
Dec 2025
+11.1%
Mar 2026
+19.5%
Jun 2026
+17.1%
Sep 2026
+9.9%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy?The Motley Fool · 1 hour ago
- Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to KnowZacks · 4 hours ago
- Novo Nordisk A/S Repurchases B Shares Under DKK 15 billion ProgrammeFintel · 22 hours ago
- FDA Orders New Eye Risk Warnings For GLP-1 Drugs Such As Ozempic, Wegovy And Zepbound RTTNews · 1 day ago
- Novo Up 4% in a Month: How Should Investors Approach the Stock Now?Zacks · 1 day ago
- Eli Lilly Is Now Worth Nearly 9 Novo Nordisks. Here's How the Gap Got So Wide.The Motley Fool · 1 day ago
- Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?The Motley Fool · 1 day ago
- What Novo Nordisk A/S (NVO) Said on Its Q3 Earnings CallMarketBeat · 1 day ago
The company
Novo is the global healthcare company that believes lasting health starts now. For over a century, we've combined leading scientific expertise with a deep understanding of people's lives. We develop treatments and support that help millions of people make progress they can see, feel and sustain now and in the future. Every day, over 67,000 employees around the world advance our purpose to drive change for lasting health. Through our partnerships, programmes and investments, we're working to prevent disease, expand access to treatments and reduce our environmental impact to help even more people live healthier lives.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- Europe
- Website
- novonordisk.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.